SBRA Stock Forecast & Price Target

Sabra Health Care REIT is benefiting from stronger senior housing and skilled nursing fundamentals, with NIC reporting 89.9% U.S. senior housing occupancy in 2Q26 and demand outpacing record-low supply growth. Operational execution is improving cash flow through the Avamere re-tenanting at about a 30% premium to trailing cash rent, more than $9 million of incremental annual cash NOI from other lease actions, and a $200 million RCA mortgage repayment that helped reduce net debt-to-EBITDA to 4.8x. Guidance also improved, with normalized AFFO per share now expected at $1.59-$1.61 for full-year 2026 and same-store SHOP NOI up 14.4% in 1Q26, supporting a positive outlook driven by growth, lower risk, and disciplined balance-sheet management.

Sabra Health Care REIT is facing a structurally fragile earnings profile because tenant operating performance, reimbursement pressure, and regulatory compliance issues can quickly impair operators’ ability to pay rent and debt obligations. Its reliance on external capital, elevated debt risk, and intensifying REIT competition could compress acquisition returns, while management’s FY26 G&A expense guidance was raised by $9 million to $61 million, including $13 million of stock-based compensation, which is dilutive to FFO. In addition, a large loan receivable matures this year and the assumed extension near the current yield, along with only 50% recovery of Avamere’s rent cut, highlight limited downside protection if lease coverage weakens or re-leasing proves difficult.